EDWARDS INTUITY Elite Valve System (8300AB)
Edwards Lifesciences, LLC · Decision date Oct 28, 2026
What did the FDA decide?
The record for P150036/S081 lists the Edwards INTUITY Elite Valve System (8300AB), product code LWR, under the PMA P150036 identifier. The supplement is a 30-Day Notice with reason "Process Change - Manufacturer/Sterilizer/Packager/Supplier," and its statement describes implementing an alternative supplier of a chemical manufacturing aid. This is a supply-chain change for a manufacturing input, not an approval of the valve system itself.
The same identifier ties the notice to the existing PMA rather than a separate filing, but the supplied fields do not identify the chemical manufacturing aid, the prior supplier, or the replacement supplier, and they do not quantify any effect. The stated purpose is a process change; the entry does not supply independent evidence of safety or clinical effectiveness, and no clinical use or new indication can be read from it.
FDA approval order statement
implementing an alternative supplier of a chemical manufacturing aid
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 28, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P150036/S081
- Regulatory pathway
- PMA supplement
- Applicant
- Edwards Lifesciences, LLC
- Product code
- LWR
- Decision code
- OK30
- Decision date
- Oct 28, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: heart-valve, non-allograft tissue.
- Applicant
- Edwards Lifesciences, LLC
- Product code
- LWR
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P150036. Subsequent supplements may change the device or its indications.
FDA decision timeline
P150036 · Original PMA
EDWARDS INTUITY ELITE VALVE SYSTEM
P150036/S081 received
Application receipt date recorded by FDA.
P150036/S081 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P150036. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P150036
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Edwards Lifesciences, LLC | PMA approval | Aug 12, 2016 | FDA |
Explore the linked device profile
Other records with product code LWR
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Edwards Lifesciences, LLC | PMA supplement | Oct 28, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Oct 22, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Sep 18, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA approval | Jun 29, 2017 | FDA | |
| ABBOTT MEDICAL | PMA approval | Aug 5, 2005 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Edwards Lifesciences, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- One Edwards Way, Irvine, CA, 92614
Sources and methodology
- Original FDA record: P150036/S081
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records